Toxicology Research is a distinguished journal dedicated to advancing the field of toxicology through the dissemination of high-quality research. Published by Oxford University Press, this UK-based journal focuses on critical aspects of toxicology and mutagenesis, highlighting both environmental and pharmacological implications. With an ISSN of 2045-452X and an E-ISSN of 2045-4538, it serves as a valuable resource for researchers, professionals, and students alike. Currently categorized in the Q3 quartile for Health, Toxicology and Mutagenesis, as well as Toxicology in 2023, Toxicology Research maintains a visible presence in Scopus rankings, positioning itself within the targeted professional community. Although the journal operates without open access options, its importance in contributing to scientific discussions and policy formation is undeniable. Covering content from 2012 to 2024, it continues to provide insights into contemporary toxicological challenges, thereby fostering interdisciplinary collaborations and informing best practices in health and safety.

YAKUGAKU ZASSHI - JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, published by the Pharmaceutical Society of Japan, is a key academic journal dedicated to advancing the field of pharmaceutical sciences. Established in 1961 and set to contribute until 2024, this journal publishes original research articles, reviews, and clinical studies that encompass a wide spectrum of topics within pharmacology, toxicology, and pharmaceutics. Although the journal operates under a traditional subscription model, it maintains a recognized reputation with an impact factor that is steadily aligned within its category quartiles—ranking Q3 in Pharmaceutical Science and Q4 in Pharmacology as of 2023. With Scopus rankings reflecting its competitive standing, YAKUGAKU ZASSHI serves as a vital resource for researchers, professionals, and students looking to engage with innovative findings and broaden their understanding of pharmaceutical methodologies and research practices. With a current focus on bridging scientific research with real-world applications, it seeks to foster collaboration and knowledge sharing within the pharmaceutical community.

Acta Scientiae Veterinariae is an esteemed academic journal dedicated to advancing knowledge in the field of veterinary sciences. Published by the Universidade Federal do Rio Grande do Sul, this journal serves as a vital platform for researchers, professionals, and students interested in the latest findings and developments in veterinary medicine and related disciplines. Operating under an open access model, Acta Scientiae Veterinariae ensures that its content is freely accessible, promoting widespread dissemination of research that contributes to the understanding and welfare of animal health. With an ISSN of 1678-0345 and an E-ISSN of 1679-9216, the journal has made a significant impact in its category, holding a Q4 ranking in the Veterinary (miscellaneous) category as per the latest 2023 categorizations and ranking in the 11th percentile, reflecting its continued relevance within the academic community. As it converges years from 2010 to 2024, Acta Scientiae Veterinariae continues to foster innovation and collaboration in veterinary research, making it an invaluable resource for those committed to enhancing animal health and veterinary practices.

Toxicology Communications is a vital academic journal published by Taylor & Francis Ltd, focusing on the critical field of toxicology. Established as an Open Access journal since 2017, it provides researchers, professionals, and students unrestricted access to significant findings in toxicological sciences, promoting global collaboration and knowledge sharing. The journal aims to disseminate innovative research, reviews, and case studies that explore the effects of chemical, biological, and physical agents on human health and the environment. With its commitment to high-quality publications, Toxicology Communications plays an essential role in advancing our understanding of toxicological phenomena and fostering safe practices across various industries. This makes it an invaluable resource for anyone dedicated to the studies of toxins and their environmental and health implications.

The Journal of Toxicological Sciences, published by the Japanese Society of Toxicological Sciences, is a prominent academic journal dedicated to the comprehensive study of toxicology and its related fields. Since its inception in 1976, the journal has provided a vital platform for researchers and professionals to disseminate innovative findings and insights in toxicology, with a focus on both experimental and clinical studies. Positioned in the Q3 quartile across various relevant categories, including Medicine (miscellaneous) and Toxicology as of 2023, the journal plays an essential role in advancing our understanding of toxic substances and their effects on biological systems. Although currently not open access, the journal maintains high academic standards and is indexed in Scopus, ranking #96 in Toxicology. Offering unique perspectives from Japan, it encourages global collaboration and discourse among toxicologists, making it an invaluable resource for students, researchers, and industry professionals alike.

Current Drug Safety is a distinguished peer-reviewed journal published by Bentham Science Publishers, focusing on the critical intersection of pharmacology and toxicology. With an ISSN of 1574-8863 and an E-ISSN of 2212-3911, this journal serves as a platform for the latest research and advances in drug safety, highlighting the importance of pharmacological assessments and toxicity evaluations in therapeutic development and public health. Reaching a broad international audience from its base in the United Arab Emirates, Current Drug Safety offers an invaluable resource for researchers, professionals, and students interested in the dynamic fields of drug research and safety management. Despite a current Q3 categorization in multiple pharmacology and toxicology quartiles for 2023, the journal continues to strive for excellence in the scholarly community, reflecting its commitment to disseminating high-quality research. While not operating under an open access model, articles can be accessed through institutional subscriptions and other platforms, ensuring valuable insights into drug safety are available to those who need it most.

International Journal of Medical Toxicology and Forensic Medicine, published by Shaheed Beheshti Medical University of Medical Sciences & Health Services, is a pioneering platform dedicated to advancing knowledge within the critical fields of toxicology and forensic medicine. Established as an Open Access journal since 2011, it ensures wide dissemination of research findings, catering to a global audience of researchers, healthcare professionals, and students. With an ISSN of 2251-8762 and an E-ISSN of 2251-8770, the journal covers a diverse range of topics relevant to the medical community, albeit being categorized as Q4 in both Pathology and Forensic Medicine and Toxicology in 2023, indicating emerging significance in these disciplines. Geographically based in Tehran, Iran, it aspires to bridge gaps in scientific research and practice, particularly in regions where such expertise is critical. The journal welcomes submissions that investigate pressing issues in medical toxicology and forensic science, fostering an interdisciplinary dialogue essential for innovative solutions and improved public health outcomes.

Ars Pharmaceutica is a distinguished open-access journal published by UNIV GRANADA, EDITORIAL, that has been at the forefront of pharmaceutical sciences since its establishment. With ISSN 0004-2927 and E-ISSN 2340-9894, this journal aims to disseminate high-quality research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of the field. With a historical scope that spans from 1980 to 2017, it has played a pivotal role in shaping the discourse surrounding pharmaceutical science and its intersection with the arts and humanities. Although currently ranked within the 13th percentile in Scopus for Pharmaceutical Science and the 11th percentile for History and Philosophy of Science, Ars Pharmaceutica continues to uphold its commitment to academic excellence and innovation. By providing a platform for open-access research, it encourages collaboration and knowledge sharing among researchers, professionals, and students, thus enhancing the broader understanding of pharmaceutical developments and their societal implications.

CLINICAL TOXICOLOGY is a prestigious journal dedicated to advancing the field of toxicology, published by Taylor & Francis Ltd. With ISSN 1556-3650 and E-ISSN 1556-9519, it has been a vital resource for researchers, clinicians, and students since its inception in 1968. The journal is recognized for its high impact, boasting a Q1 quartile ranking in both the categories of Medicine (miscellaneous) and Toxicology as of 2023, reflecting its reputation for disseminating significant contributions to the field. CLINICAL TOXICOLOGY primarily features original research, reviews, and case reports that explore the latest advancements and methodologies in the diagnosis and management of toxic exposures, making it an essential tool for professionals seeking to stay abreast of current trends and best practices. The journal's open access options ensure that its content is readily available to a wide audience, thereby promoting the exchange of knowledge and collaborative efforts within the global scientific community. For those committed to improving public health outcomes through toxicological research, CLINICAL TOXICOLOGY provides an indispensable platform for publication and discourse.

Exposure and Health is a pioneering journal published by Springer, specializing in the interdisciplinary fields of health, toxicology, and environmental sciences. With an ISSN of 2451-9766 and E-ISSN of 2451-9685, this open-access journal exemplifies a commitment to disseminating high-quality research that informs public health practices and policies globally. Situated in the Netherlands, it boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple categories in the 2023 Scopus rankings, including Health, Toxicology and Mutagenesis, Pollution, and Water Science and Technology. The journal is dedicated to advancing knowledge on the interactions between environmental factors and health outcomes, making it a vital resource for researchers, professionals, and students in these critical fields. Exposure and Health actively encourages submissions that address the challenges of exposure assessment, risk management, and the promotion of sustainable public health initiatives.